Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the PERFUSE Study

Title:	Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the PERFUSE Study
Authors:	Fautrel, Bruno^Aff1; Bouhnik, Yoram^Aff2; Salliot, Carine^Aff3; Carbonnel, Franck^Aff4; Fumery, Mathurin^Aff5; Bernardeau, Christophe^Aff6; Maugars, Yves^{Aff7, Aff8, Aff9}; Flamant, Mathurin^Aff10; Coury, Fabienne^{Aff11, Aff12}; Braithwaite, Ben^{Aff13, IDs40801024004596_cor1}; Hateb, Salima^Aff14; Addison, Janet^Aff15
Source:	Drugs - Real World Outcomes. 11(4):573-591
Database:	Springer Nature Journals